For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Search Posts
Op-Eds
Science vs. Presumption In Assessing Risk
Full Chapter Available in PDF Format On September 22, 2000, California Governor Gray Davis signed into…
Op-Eds
European move will stifle GMOs
Regulatory officials in the European Union seem to be ignorant of the Rule of Holes: When you're in a hole, stop digging. Repeated analyzes…
Op-Eds
Blessed Are The Poor With Spirit
This year's UN-sponsored World Food Summit just concluded with a grim reminder that the goal of cutting world hunger in half by 2015 set six…
Op-Eds
Biotech Critics Find A Little Goes A Long Way
In the fictional world of James Bond, the criminal group SPECTRE made a big business out of misusing technology to disrupt commerce, make money, and…
Comment
Are Risk Assessment And The Precautionary Principle Equivalent?
EDITOR’S NOTE: The following paper was prepared for the June 20-21, 2002 International Society of Regulatory Toxicology and Pharmacology workshop on the Precautionary Principle,…
Comment
The Precautionary Principle: Protectionism and Environmental Extremism by Other Means
The Precautionary Principle: Protectionism and Environmental Extremism by Other Means …